Synthesis of 1,2,3-triazolyl nucleoside analogs as potential anti-influenza A (H3N2 subtype) virus agents

Archiv der Pharmazie

Volumn 347, Issue 2, 2014, Pages 134-141

  Elayadi, Hanane ^a   Smietana, Michael ^b   Vasseur, Jean J ^b   Balzarini, Jan ^c   Lazrek, Hassan B ^a  

^a FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

1,2,3 Triazolyl nucleoside; Anti influenza A (H3N2); Click reaction

Indexed keywords

1,2,3 TRIAZOLYL NUCLEOSIDE ANALOG; 2 [1 BENZYL 1,2,3 TRIAZOL 4 YL METHYL]5 BROMOURACIL; 2 [1 BENZYL 1,2,3 TRIAZOL 4 YL METHYL]5 FLUOROURACIL; 2 [1 BENZYL 1,2,3 TRIAZOL 4 YL METHYL]5 IODOURACIL; 2 [1 BENZYL 1,2,3 TRIAZOL 4 YL METHYL]6 AZAURACIL; 2 [1 BENZYL 1,2,3 TRIAZOL 4 YL METHYL]THYMINE; 2 [1 BENZYL 1,2,3 TRIAZOL 4 YL-METHYL]URACIL; 2 [1 BENZYL 1,2,3, TRIAZOL 4 YL METHYL]5 CHLOROURACIL; 7 [1 BENZYL 1,2,3 TRIAZOLE 4 YL METHYL]ADENINE; ANTIVIRUS AGENT; MONTMORILLONITE; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYST; COXSACKIE VIRUS B4; CYCLOADDITION; CYTOMEGALOVIRUS; CYTOTOXICITY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAMMALIAN ORTHOREOVIRUS; MDCK CELL; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PUNTA TORO VIRUS; SINDBIS VIRUS; SYNTHESIS; THIN LAYER CHROMATOGRAPHY; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS;

1,2,3-TRIAZOLYL NUCLEOSIDE; ANTI-INFLUENZA A (H3N2); CLICK REACTION;

ANIMALS; ANTIVIRAL AGENTS; CATS; CERCOPITHECUS AETHIOPS; DOGS; DRUG DESIGN; HELA CELLS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MOLECULAR STRUCTURE; NUCLEOSIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES; VERO CELLS;

EID: 84893762431     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201300260     Document Type: Article

References (32)

1. a) M. Samson, A. Pizzorno, Y. Abed, G. Boivin, Antivir. Res. 2013, 98, 174-185
2. b) A. Pizzorno, Y. Abed, G. Boivin, Semin. Respir. Crit. Care Med. 2011, 32, 409-422.
3. S.-T. Xue, W.-Y. He, L.-L. Ma, H.-Q. Wang, B. Wang, G.-H. Zheng, X.-Y. Ji, T. Zhang, Y.-H. Li, J. D. Jiang, Z.-R. Li, Molecules 2013, 18, 3789-3805.
4. M. J. Genin, D. A. Allwine, D. J. Anderson, M. R. Barbachyn, D. E. Emmert, S. A. Garmon, D. R. Graber, K. C. Grega, J. B. Hester, D. K. Hutchinson, J. Morris, R. J. Reischer, C. W. Ford, G. E. Zurenko, J. C. Hamel, R. D. Schaadt, D. Stapert, B. H. Yagi, J. Med. Chem. 2000, 43, 953-970.
5. a) R. Alvarez, S. Velazquez, A. San-Felix, S. Aquaro, E. De Clercq, C. F. Perno, A. Karlsson, J. Balzarini, M. J. Camarasa, J. Med. Chem. 1994, 37, 4185-4194
6. b) J. Wu, W. Yu, L. Fu, W. He, Y. Wang, B. Chai, C. Song, J. Chang, Eur. J. Med. Chem. 2013, 63, 739-745.
7. a) M. Von Itzstein, Nat. Rev. Drug Discovery 2007, 6, 967-974
8. b) A. Padwa, Huisgen, 1,3-Dipolar Cycloaddition Chemistry, Wiley, New York 1984
9. c) H. Lõpez-Ruiz, J. E. de la Cerda-Pedro, S. Rojas-Lima, I. Pérez-Pérez, V. Rodríguez-Sánchez, R. Santillan, O. Coreño, ARKIVOC 2013, (iii), 139-164.
10. a) V. O. Rodionov, S. I. Presolski, S. Gardinier, Y.-H. Lim, M. G. Finn, J. Am. Chem. Soc. 2007, 129, 12696-12704
11. b) G. E. Negrõn-Silva, R. González-Olvera, D. Angeles-Beltrán, N. Maldonado-Carmona, A. Espinoza-Vázquez, M. E. Palomar-Pardavé, M. A. Romero-Romo, R. Santillan, Molecules 2013, 18, 4613-4627.
12. V. O. Rodionov, S. I. Presolski, D. Díaz Díaz, V. V. Fokin, M. G. Finn, J. Am. Chem. Soc. 2007, 129, 12705-12712.
13. M. Hosseini-Sarvari, S. Etemad, Tetrahedron 2008, 64, 5519-5523.
14. a) S. Chassaing, M. Kumarraja, A. S. S. Sido, P. Pale, J. Sommer, J. Org. Lett. 2007, 9, 883-886
15. b) A. Alix, S. Chassaing, P. Pale, J. Sommer, Tetrahedron 2008, 64, 8922-8929.
16. B. H. Lipshutz, B. R. Taft, Angew. Chem., Int. Ed. 2006, 45, 8235-8823.
17. N. Candeon, D. Lastécouères, A. K. Diallo, J. R. Aranzaes, D. Astruc, J. M. Vincent, Chem. Commun. 2008, 6, 741-743.
18. K. Namitharan, M. Kumarraja, K. Pitchumani, Chem. Eur. J. 2009, 15, 2755-2758.
19. C. Girard, E. Onen, M. Aufort, S. Beauvière, E. Samson, J. Herscovici, Org. Lett. 2006, 8, 1689-1692.
20. a) Y. Kabbaj, H. B. Lazrek, J. L. Barascut, J. L. Imbach, Nucleos. Nucleot. Nucleic Acids 2005, 24, 161-172
21. b) H. B. Lazrek, M. Taourirte, T. Oulih, J. L. Barascut, J. L. Imbach, C. Pannecouque, M. Witrouw, E. De Clercq, Nucleos Nucleot Nucleic Acids 2001, 20, 1949-1960
22. c) O. Moukha-chafiq, M. L. Taha, H. B. Lazrek, J. J. Vasseur, C. Pannecouque, M. Witvrouw, E. De Clercq, Farmaco 2002, 57, 27-32
23. d) O. Moukha-Chafiq, M. L. Taha, H. B. Lazrek, J. J. Vasseur, C. Pannecouque, M. Witvrouw, E. De Clercq, Nucleos Nucleot Nucleic Acids 2001, 20, 1811-1821
24. e) H. Elayadi, M. Smietana, C. Pannecouque, P. Leyssen, J. Neyts, J. J. Vasseur, H. B. Lazrek, Bioorg. Med. Chem. Lett. 2010, 20, 7365-7368.
25. N. Kirai, Y. Yamamoto, Eur. J. Org. Chem. 2009, 1864-1867.
26. P. Siemens, R. C. Livingston, F. Diederich, Angew. Chem., Int. Ed. 2000, 39, 2632-2657.
27. G. Eglinton, A. R. Galbraith, Chem. Ind. (Lond.) 1956, 737-738.
28. W. S. Brotherton, H. A. Michaels, J. T. Simmons, R. J. Clark, N. S. Dalal, L. Zhu, Org. Lett. 2009, 11, 4954-4957.
29. a) A. Stimac, J. Kobe, Carbohydr. Res. 2000, 324, 149
30. b) M. J. Camarasa, R. Alonso, F. G. De Las Heras, Carbohydr. Res. 1980, 83, 152-156.
31. a) H. Elayadi, H. B. Lazrek, M. Mesnaoui, B. E. Korba, M. Smietana, J. J. Vasseur, J. A. Secrist, Arkivoc 2012, (viii), 76-89
32. b) H. Elayadi, M. Ait Ali, A. Mehdi, H. B. Lazrek, Catal. Commun. 2012, 26, 155.